Personalized Therapy for Breast Cancer: How Long More to be There?

Personalized Therapy for Breast Cancer: How Long More to be There?

NA

Bibliographic Details
Main Authors:	Elham Fakhrejahani, Shigehira Saji, Masakazu Toi
Format:	Article
Language:	English
Published:	Kaviani Breast Disease Institute 2014-11-01
Series:	Archives of Breast Cancer
Online Access:	https://archbreastcancer.com/index.php/abc/article/view/17

Similar Items

Impact of body mass index on breast cancer in accordance with the life-stage of women
by: Reiko eSuzuki, et al.
Published: (2012-10-01)

Tumor Angiogenesis: Pericytes and Maturation Are Not to Be Ignored
by: Elham Fakhrejahani, et al.
Published: (2012-01-01)

Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR
by: Takayuki Ueno, et al.
Published: (2019-02-01)

Breast Cancer Susceptibility Genetic Testing; Where Should Medical Professionals Stand Between Providers and Customers?
by: Elham Fakhrejahani
Published: (2017-10-01)

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication
by: Hiroji Iwata, et al.
Published: (2019-02-01)

Neoadjuvant endocrine therapy with exemestane followed by response‐guided combination therapy with low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer: A multicenter, open‐label, phase II study
by: Nobuaki Sato, et al.
Published: (2018-07-01)

Estradiol promotes rapid degradation of HER3 in ER-positive breast cancer cell line MCF-7
by: Junko Suga, et al.
Published: (2018-12-01)

Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor‐positive breast cancer: A multicenter, open‐label, phase II study
by: Nobuaki Sato, et al.
Published: (2019-09-01)

Clinical Report on the First Prototype of a Photoacoustic Tomography System with Dual Illumination for Breast Cancer Imaging.
by: Elham Fakhrejahani, et al.
Published: (2015-01-01)

Optimal management of luminal breast cancer: how much endocrine therapy is long enough?
by: Elisabetta Munzone, et al.
Published: (2018-06-01)

Religious, Cultural, and Social Beliefs of Iranian Rural Women about Breast Cancer: A Qualitative Study
by: Iman Ghaderi, et al.
Published: (2014-05-01)

Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer
by: Masuda Norikazu, et al.
Published: (2010-02-01)

Innovations in Personalized and Targeted Therapies for Breast Cancer
by: Eleanor E. R. Harris, et al.
Published: (2018-01-01)

Vascular branching point counts using photoacoustic imaging in the superficial layer of the breast: A potential biomarker for breast cancer
by: Iku Yamaga, et al.
Published: (2018-09-01)

The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation
by: Yuka Ono, et al.
Published: (2019-07-01)

Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System
by: Takayuki Ueno, et al.
Published: (2015-01-01)

Breast cancer patient delay in Fukushima, Japan following the 2011 triple disaster: a long-term retrospective study
by: Akihiko Ozaki, et al.
Published: (2017-06-01)

The Changing Landscape of Breast Cancer: How Biology Drives Therapy
by: Sarah Friend, et al.
Published: (2016-01-01)

A personal portrayal of breast cancer : how art can educate
by: Dlusy-Apel, Deena
Published: (2001)

Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
by: Valentina Bianchi, et al.
Published: (2020-06-01)

Precision medicine and personalized breast cancer: combination pertuzumab therapy
by: Reynolds K, et al.
Published: (2014-03-01)

Data of a fluorescent imaging-based analysis of anti-cancer drug effects on three-dimensional cultures of breast cancer cells
by: Junji Itou, et al.
Published: (2015-12-01)

The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients
by: Sunao Tanaka, et al.
Published: (2017-04-01)

Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups
by: Stephen Johnston, et al.
Published: (2021-06-01)

Metastatic Colorectal Cancer in the Era of Personalized Medicine: A More Tailored Approach to Systemic Therapy
by: Irene S. Yu, et al.
Published: (2018-01-01)

Guidelines, guidelines and more guidelines: And we still do not know how to follow-up patients with breast cancer
by: Hutcheon Andrew W, et al.
Published: (2005-08-01)

Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer
by: Toshihiko Takeiwa, et al.
Published: (2020-05-01)

Screening prior to Breast Cancer Diagnosis: The More Things Change, the More They Stay the Same
by: Erica B. Friedman, et al.
Published: (2013-01-01)

Triple-Negative Breast Cancer: One Or More Entities?
by: Matikas Alexios, et al.
Published: (2014-12-01)

Estrogen and breast cancer: can less mean more?
by: Bullock, Marc D., et al.
Published: (2015)

Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers
by: Ryan A. Denu, et al.
Published: (2017-01-01)

Patient-Specific Network for Personalized Breast Cancer Therapy with Multi-Omics Data
by: Claudia Cava, et al.
Published: (2021-02-01)

Opportunities of the pharmacogenetic approach to personalized tamoxifen breast cancer therapy: case reports
by: Marina I Savelyeva, et al.
Published: (2019-03-01)

Long Non-Coding RNA <i>HOTAIR</i> in Breast Cancer Therapy
by: Monica Cantile, et al.
Published: (2020-05-01)

A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer
by: Yoshikazu Masai, et al.
Published: (2010-04-01)

Clinical Practice for Radiation Therapy in Breast Cancer
by: Shadi Babazadeh, et al.
Published: (2015-02-01)

Breast Cancer Awareness Is More Than a Pink Ribbon
by: Joy Galloni
Published: (2009-08-01)

Breast cancer screening causes more harm than good: No
by: Duffy SW
Published: (2014-03-01)

Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells.
by: Takehiro Ichikawa, et al.
Published: (2012-01-01)

HER2-positive breast cancer with brain metastasis, long responder to lapatinib therapy
by: Chiara Saggia
Published: (2018-06-01)